Sanjay Govil, the US-based tech entrepreneur and owner of Washington Freedom, is set to buy a minority stake in Welsh Fire, ...
– Proceeds will support two double-blind Phase 2 clinical trials of lead candidate, XC001, which has demonstrated transformative potential for treatment of refractory angina KING OF PRUSSIA, Pa ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results